Enterprise Value
-18.9M
Cash
251.5M
Avg Qtr Burn
-25.48M
Short % of Float
4.93%
Insider Ownership
36.04%
Institutional Own.
55.28%
Qtr Updated
03/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
CNTY-101 Details Cancer, Relapsed/ refractory lymphoma | Phase 1 Data readout |